Immunology Laboratory, National JALMA Institute for Leprosy and Other Mycobacterial Diseases-ICMR, Dr. M. Miyazaki Marg, Tajganj, Agra 282001, India.
Lipids Health Dis. 2012 Sep 17;11:119. doi: 10.1186/1476-511X-11-119.
Advanced stages of leprosy show T cell unresponsiveness and lipids of mycobacterial origin are speculated to modulate immune responses in these patients. Present study elucidates the role of phenolicglycolipid (PGL-1) and Mannose-capped lipoarabinomannan (Man-LAM) on TCR- and TCR/CD28- mediated signalling.
We observed that lipid antigens significantly inhibit proximal early signalling events like Zap-70 phosphorylation and calcium mobilization. Interestingly, these antigens preferentially curtailed TCR-triggered early downstream signalling events like p38 phosphorylation whereas potentiated that of Erk1/2. Further, at later stages inhibition of NFAT binding, IL-2 message, CD25 expression and T-cell blastogenesis by PGL-1 and Man-LAM was noted.
Altogether, we report that Man-LAM and PGL-1 preferentially interfere with TCR/CD28-triggered upstream cell signalling events, leading to reduced IL-2 secretion and T-cell blastogenesis which potentially could lead to immunosupression and thus, disease exacerbation, as noted in disease spectrum.
麻风病的晚期阶段表现出 T 细胞无反应性,推测分枝杆菌来源的脂质可以调节这些患者的免疫反应。本研究阐明了酚基甘油糖脂(PGL-1)和甘露糖封端的脂阿拉伯甘露聚糖(Man-LAM)在 TCR 和 TCR/CD28 介导的信号转导中的作用。
我们观察到脂质抗原显著抑制 Zap-70 磷酸化和钙动员等早期近端信号事件。有趣的是,这些抗原优先抑制 TCR 触发的早期下游信号事件,如 p38 磷酸化,而增强 Erk1/2 的磷酸化。此外,还观察到 PGL-1 和 Man-LAM 在后期抑制 NFAT 结合、IL-2 消息、CD25 表达和 T 细胞增殖。
总之,我们报告称,Man-LAM 和 PGL-1 优先干扰 TCR/CD28 触发的上游细胞信号事件,导致 IL-2 分泌减少和 T 细胞增殖减少,这可能导致免疫抑制,从而导致疾病恶化,如疾病谱中所观察到的那样。